HA
ELOS

Havens Advisors’s Syneron Medical Ltd ELOS Stock Holding History

Havens Advisors’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-280,200
Closed -$3.07M – 37
2017
Q2 		$3.07M Buy
+280,200
New +$3.07M 2.19% 19

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Havens Advisors's ELOS Position: Q3 2017 in Review

Havens Advisors sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 280,200 shares — an estimated $3.07M sold.

Havens Advisors first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $3.07M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Havens Advisors reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Havens Advisors sold 280,200 Syneron Medical Ltd shares in Q3 2017, an estimated $3.07M.
  • Havens Advisors first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
  • Havens Advisors's Syneron Medical Ltd position peaked at $3.07M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Havens Advisors's 13F filing for Q3 2017, filed 23 Oct 2017.